{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:05:37Z","timestamp":1772845537617,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.diabet.2009.06.003","type":"journal-article","created":{"date-parts":[[2009,11,8]],"date-time":"2009-11-08T04:15:38Z","timestamp":1257653738000},"page":"484-489","source":"Crossref","is-referenced-by-count":35,"title":["Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes"],"prefix":"10.1016","volume":"35","author":[{"given":"Michel P.","family":"Hermans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie A.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel F.","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2009.06.003_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000019929","article-title":"Is obesity an underlying factor in erectile dysfunction?","volume":"36","author":"Chung","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.diabet.2009.06.003_bib2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/diacare.28.5.1201","article-title":"High proportions of erectile dysfunction in men with the metabolic syndrome","volume":"28","author":"Esposito","year":"2005","journal-title":"Diabet Care"},{"key":"10.1016\/j.diabet.2009.06.003_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1464-410X.2005.05780.x","article-title":"Plasma levels of endothelin-1, angiotensin II, nitric oxide and prostaglandin E in the venous and cavernosal blood of patients with erectile dysfunction","volume":"96","author":"El Melegy","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.diabet.2009.06.003_bib4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.fertnstert.2007.01.116","article-title":"Erectile dysfunction: does insulin resistance play a part?","volume":"88","author":"Trussell","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.diabet.2009.06.003_bib5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.jacc.2008.02.051","article-title":"Erectile dysfunction predicts coronary heart disease in type 2 diabetes","volume":"51","author":"Ma","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabet.2009.06.003_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1464-5491.2007.02298.x","article-title":"Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes","volume":"25","author":"Aversa","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2009.06.003_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1464-5491.2003.00869.x","article-title":"Pathophysiological implications of insulin resistance on vascular endothelial function","volume":"20","author":"Wheatcroft","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2009.06.003_bib8","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2009.06.003_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.dsx.2007.09.001","article-title":"The metabolic syndrome phenotype is associated with raised circulating Big endothelin-1 independently of coronary artery disease in type 2 diabetes","volume":"1","author":"Hermans","year":"2007","journal-title":"Diab Met Syndr Clin Res Rev"},{"key":"10.1016\/j.diabet.2009.06.003_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2009.06.003_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2337\/diacare.27.1.201","article-title":"UKPDS, 66, risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes","volume":"27","author":"Stevens","year":"2004","journal-title":"Diabet Care"},{"key":"10.1016\/j.diabet.2009.06.003_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.dsx.2008.02.001","article-title":"Neurohormonal biomarkers and UKPDS stroke risk in type 2 diabetic women on primary cardiovascular prevention","volume":"2","author":"Hermans","year":"2008","journal-title":"Diab Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.diabet.2009.06.003_bib13","doi-asserted-by":"crossref","unstructured":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183\u201397.","DOI":"10.2337\/diacare.20.7.1183"},{"key":"10.1016\/j.diabet.2009.06.003_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.dsx.2008.02.004","article-title":"Phenotypic characterization of first generation Maghrebian migrants with type 2 diabetes: A gender-based comparison with a reference North-Caucasian Belgian cohort","volume":"2","author":"Munoko","year":"2008","journal-title":"Diab Met Syndr Clin Res Rev"},{"key":"10.1016\/j.diabet.2009.06.003_bib15","doi-asserted-by":"crossref","unstructured":"Hermans MP, Ahn SA, Rousseau MF. Cardiometabolic phenotype and UKPDS risk in male type 2 diabetic patients with obstructive sleep apnoea. Diab Met Syndr Clin Res Rev 2009;3:50\u20134.","DOI":"10.1016\/j.dsx.2008.10.011"},{"key":"10.1016\/j.diabet.2009.06.003_bib16","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2009.06.003_bib17","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabet Care"},{"key":"10.1016\/j.diabet.2009.06.003_bib18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s001250051215","article-title":"Comparison of insulin sensitivity tests across a range of glucose tolerance form normal to diabetes","volume":"42","author":"Hermans","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2009.06.003_bib19","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3132\/dvdr.2007.019","article-title":"Diabetic macro- and microvascular disease in type 2 diabetes","volume":"4","author":"Hermans","year":"2007","journal-title":"Diabet Vasc Dis Res"},{"key":"10.1016\/j.diabet.2009.06.003_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.dsx.2007.11.008","article-title":"Metabolic syndrome in Bantu subjects with type 2 diabetes from sub-Saharan extraction: Prevalence, gender differences and HOMA hyperbolic product","volume":"2","author":"Dehout","year":"2008","journal-title":"Diab Met Syndr Clin Res Rev"},{"key":"10.1016\/j.diabet.2009.06.003_bib21","first-page":"329","article-title":"Erectile dysfunction and lower androgenicity in type 1 diabetic patients","volume":"27","author":"Alexopoulou","year":"2001","journal-title":"Diabet Metab"},{"key":"10.1016\/j.diabet.2009.06.003_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3132\/dvdr.2008.046","article-title":"The Residual Risk Reduction initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients","volume":"5","author":"Fruchart","year":"2008","journal-title":"Diabet Vasc Dis Res"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363609001773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363609001773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T14:30:57Z","timestamp":1558621857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363609001773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1262363609001773"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2009.06.003","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}